7.1 Parkinson's Disease & Movement Disorders

Parkinson's Disease & Movement Disorders

Pathophysiology of Parkinson's Disease

Parkinson's disease (PD) is a progressive, neurodegenerative movement disorder characterized by the profound loss of dopaminergic neurons, primarily located in the substantia nigra pars compacta of the basal ganglia. The basal ganglia are responsible for the smooth coordination and execution of voluntary motor movements. In a healthy neurological system, a delicate balance exists between dopamine (an inhibitory neurotransmitter) and acetylcholine (an excitatory neurotransmitter). When the substantia nigra undergoes dopamine depletion, this critical equilibrium is disrupted, leading to an overactivity of acetylcholine. This excessive excitatory signaling pathway results in the hallmark motor symptoms of the disease. The pathological hallmark of Parkinson's disease is the presence of Lewy bodies—intracytoplasmic inclusions composed largely of alpha-synuclein proteins—within the degenerating neurons. This progressive neurodegeneration extends beyond the basal ganglia, eventually affecting the cortex, brainstem, and peripheral autonomic nervous system, which accounts for the widespread non-motor symptoms associated with the condition. As the disease advances, the continued loss of dopaminergic pathways leads to severe motor fluctuations and increasingly complex clinical presentations that require advanced nursing management and multidisciplinary care.

Clinical Manifestations: The TRAP Assessment

The clinical diagnosis of Parkinson's disease relies heavily on the identification of specific motor deficits, commonly remembered by the TRAP acronym. Tremor is typically a "pill-rolling" resting tremor that is most prominent when the limb is fully supported and at rest. It often begins unilaterally and may decrease with purposeful movement or during sleep. Rigidity is characterized by increased resistance to passive movement of a joint throughout its entire range of motion. It may present as "cogwheel" rigidity (a jerky, ratchety resistance) or "lead-pipe" rigidity (a sustained, smooth resistance). Akinesia/Bradykinesia refers to the absence or slowness of movement. This is often the most disabling symptom, manifesting as a loss of spontaneous movements (e.g., decreased arm swing while walking, masked facies or hypomimia, decreased blink rate) and profound difficulty initiating voluntary movements. Postural instability is a later manifestation involving the loss of postural reflexes. Patients are highly susceptible to falls, typically falling backward (retropulsion) or forward (propulsion) due to an inability to correct their center of gravity. Furthermore, non-motor symptoms such as autonomic dysfunction, orthostatic hypotension, constipation, REM sleep behavior disorder, and cognitive impairment often precede motor symptoms and significantly impact the patient's quality of life, requiring astute nursing assessment.

Pharmacological Management

The cornerstone of Parkinson's disease management is pharmacological dopamine replacement and conservation. Nursing education regarding strict adherence to the medication schedule is paramount, as delayed doses can precipitate severe "off" periods where the patient becomes entirely immobile. Levodopa/carbidopa remains the gold standard therapy. Levodopa crosses the blood-brain barrier and is converted into dopamine. Carbidopa prevents the peripheral breakdown of levodopa, allowing a greater concentration to reach the CNS while minimizing peripheral side effects like profound nausea. A critical nursing consideration is that dietary proteins can compete with levodopa for absorption; therefore, it should be taken on an empty stomach or with a low-protein snack. Dopamine agonists directly stimulate postsynaptic dopamine receptors and are used early in the disease or as adjuncts. Nurses must monitor for severe side effects, including sudden sleep attacks, orthostatic hypotension, and impulse control disorders. MAO-B Inhibitors inhibit the breakdown of dopamine in the brain. Patients must be educated on the risk of serotonin syndrome if combined with certain antidepressants. COMT Inhibitors are solely used as adjuncts to levodopa to manage "wearing-off" periods, and may cause a benign orange-brown discoloration of urine. The precise administration and constant evaluation of these pharmacological agents form the bedrock of CNRN practice in movement disorders.

Surgical Interventions: Deep Brain Stimulation (DBS)

For patients who experience severe, intractable motor fluctuations or disabling dyskinesias despite optimized pharmacological therapy, surgical intervention may be indicated. Deep Brain Stimulation (DBS) involves the surgical implantation of electrodes into precise target areas of the brain—most commonly the subthalamic nucleus (STN) or the globus pallidus internus (GPi). These electrodes are connected to an implanted pulse generator (IPG) placed subcutaneously in the subclavicular space. DBS delivers high-frequency electrical stimulation that overrides abnormal neural firing patterns, significantly reducing tremor, rigidity, and bradykinesia, and allowing for a reduction in dopaminergic medication dosages. Postoperative nursing care focuses on rigorous neurological assessments, monitoring for intracranial hemorrhage, managing infection risks at the surgical sites, and assessing for device-related complications such as hardware malfunction or stimulation-induced side effects (e.g., dysarthria, paresthesia, muscle contractions). The nurse plays a critical role in educating the patient about living with a DBS device, including avoiding certain electromagnetic fields and understanding the programming process.

Nursing Care, Interventions, and Patient Education

Comprehensive nursing management of the Parkinson's disease patient is multifaceted and heavily prioritizes safety, mobility, and nutrition. Due to postural instability and bradykinesia, patients are at a critically high risk for falls. Nurses should educate patients to use a broad-based gait, consciously lift their feet to avoid the shuffling gait (festination), and use assistive devices as prescribed. "Freezing of gait" can be managed by teaching patients to step over imaginary lines on the floor or using rhythmic cues. Dysphagia is highly prevalent and can lead to silent aspiration and life-threatening aspiration pneumonia. Nursing interventions include collaborating with speech-language pathology, providing thickened liquids, ensuring the patient is seated upright at 90 degrees during and after meals, and monitoring weight. Exact timing of medications is non-negotiable. Nurses must meticulously coordinate medication administration with meal times and physical therapy sessions. Additionally, robust psychosocial support for both the patient and caregivers is vital due to the progressive nature of the disease and the high incidence of depression. Nurses must also be acutely aware of advanced directives and palliative care integration early in the disease process. As Parkinson's disease advances to Stage 4 and Stage 5 on the Hoehn and Yahr scale, the focus of care shifts intensely toward maximizing comfort, preventing skin breakdown due to immobility, and managing the severe neuropsychiatric complications such as Parkinson's disease dementia and visual hallucinations. Collaboration with a multidisciplinary team, including neurologists, physical therapists, occupational therapists, speech therapists, and social workers, is absolutely essential to provide holistic and effective care.